Skip Navigation
National Institutes of Health: National Cancer Institute: Division of Cancer Control and Population Sciences
Grant Details

Grant Number: 5R01CA089085-05 Interpret this number
Primary Investigator: Olopade, Olufunmilayo
Organization: University Of Chicago
Project Title: Genetics of Breast Cancer in Blacks
Fiscal Year: 2006
Back to top


DESCRIPTION (provided by applicant): African Americans and Africans experience a disproportionate burden of pre-menopausal breast cancer for reasons that remain unknown. The identification of persons carrying breast cancer susceptibility genes is a promising approach to understanding the etiology of the disease and developing more effective early detection and prevention strategies. With the cloning of BRCA1 and BRCA2 genes, there is an urgent need to identify mutations among different ethnic populations in order to study mutation spectrum, age-specific penetrance, risks of other cancers, epidemiological risk factors, and effects of modifier genes for mutation carriers. It is more than 6 years since BRCA1was cloned and yet, there is little information available about the role of BRCA1and BRCA2 for ethnic groups other than Caucasians of Northern European ancestry. Our proposal aims to narrow the knowledge gap by examining a large cohort of African American and African breast cancer cases. We propose to ascertain a total of 1000 Nigerian women diagnosed with breast cancer at, or before, age 65, and 1000 controls. All women under the age of 45 and women with a family history of breast or ovarian cancer, or bilateral breast cancer will be screened for BRCA1 and BRCA2 mutations. The incidence and spectrum of mutations identified in these cases will be compared to that previously reported in Caucasian women and to that obtained in 360 African American women from Northern California who are participating in the Cooperative Family Registry for Breast Cancer Studies (CFRBCS). Detailed family cancer history and exposure information will be collected on each participant to determine whether differences exist in exposure history and clustering of breast and other cancers in the families of women with breast cancer, in Nigeria and the United States. Penetrance of BRCA mutations will be estimated for African American and Nigerian kindreds that are segregating a deleterious mutation. UGT1A1 enzyme is one of the major UGT involved in estradiol glucunonidation and also constitutes a major detoxification pathway for toxic or carcinogenic compounds. We have found that populations of African Origin harbor four different alleles of UGT1A1 while non-African populations appear to have only two alleles. In addition, alleles associated with lower gene expression levels reach the highest frequency in populations of sub-Saharan African. Using the resources of the CFRBCS and those collected in this study, the association between single nucleotide polymorphisms and in a number of the genes in the UGTIA cluster and breast cancer will be assessed in a Nigerian case-control study and an African-American case-control study. In addition, UGTIA polymorphisms will be examined as a potential modifies of BRCA1 or BRCA2 cancer risk The accurate definition of genetic risks for young Black women will eventually lead to more accurate clinical risk assessment and the development of targeted prevention, early detection and treatment strategies that should ultimately lead to reduced breast cancer mortality and improved clinical outcomes in young women of African ancestry.

Back to top


A comprehensive examination of breast cancer risk loci in African American women.
Authors: Feng Y. , Stram D.O. , Rhie S.K. , Millikan R.C. , Ambrosone C.B. , John E.M. , Bernstein L. , Zheng W. , Olshan A.F. , Hu J.J. , et al. .
Source: Human molecular genetics, 2014-10-15; 23(20), p. 5518-26.
EPub date: 2014-05-22.
PMID: 24852375
Related Citations

Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.
Authors: Hou N. , Ogundiran T. , Ojengbede O. , Morhason-Bello I. , Zheng Y. , Fackenthal J. , Adebamowo C. , Anetor I. , Akinleye S. , Olopade O.I. , et al. .
Source: Annals of epidemiology, 2013 Sep; 23(9), p. 551-7.
EPub date: 2013-07-20.
PMID: 23880155
Related Citations

Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
Authors: Zheng Y. , Ogundiran T.O. , Falusi A.G. , Nathanson K.L. , John E.M. , Hennis A.J. , Ambs S. , Domchek S.M. , Rebbeck T.R. , Simon M.S. , et al. .
Source: Carcinogenesis, 2013 Jul; 34(7), p. 1520-8.
EPub date: 2013-03-08.
PMID: 23475944
Related Citations

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.
Authors: Stacey S.N. , Sulem P. , Zanon C. , Gudjonsson S.A. , Thorleifsson G. , Helgason A. , Jonasdottir A. , Besenbacher S. , Kostic J.P. , Fackenthal J.D. , et al. .
Source: PLoS genetics, 2010 Jul; 6(7), p. e1001029.
EPub date: 2010-07-22.
PMID: 20661439
Related Citations

Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population.
Authors: Zhang J. , Fackenthal J.D. , Huo D. , Zheng Y. , Olopade O.I. .
Source: Breast cancer research and treatment, 2010 Nov; 124(2), p. 573-7.
EPub date: 2010-07-02.
PMID: 20596889
Related Citations

Advances in breast cancer: pathways to personalized medicine.
Authors: Olopade O.I. , Grushko T.A. , Nanda R. , Huo D. .
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2008-12-15; 14(24), p. 7988-99.
PMID: 19088015
Related Citations

MYC in breast tumor progression.
Authors: Chen Y. , Olopade O.I. .
Source: Expert review of anticancer therapy, 2008 Oct; 8(10), p. 1689-98.
PMID: 18925859
Related Citations

Translational integrity and continuity: personalized biomedical data integration.
Authors: Wang X. , Liu L. , Fackenthal J. , Cummings S. , Cook M. , Hope K. , Silverstein J.C. , Olopade O.I. .
Source: Journal of biomedical informatics, 2009 Feb; 42(1), p. 100-12.
EPub date: 2008-08-12.
PMID: 18760382
Related Citations

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
Authors: Stacey S.N. , Manolescu A. , Sulem P. , Thorlacius S. , Gudjonsson S.A. , Jonsson G.F. , Jakobsdottir M. , Bergthorsson J.T. , Gudmundsson J. , Aben K.K. , et al. .
Source: Nature genetics, 2008 Jun; 40(6), p. 703-6.
EPub date: 2008-04-27.
PMID: 18438407
Related Citations

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Authors: Nanda R. , Schumm L.P. , Cummings S. , Fackenthal J.D. , Sveen L. , Ademuyiwa F. , Cobleigh M. , Esserman L. , Lindor N.M. , Neuhausen S.L. , et al. .
Source: JAMA, 2005-10-19; 294(15), p. 1925-33.
PMID: 16234499
Related Citations